Arno de Wilde

Risk of Bias in Reports of In Vivo Research: A Focus for Improvement

Malcolm Macleod, Aaron Lawson McLean, Aikaterini Kyriakopoulou et al. · PLoS Biology · 2015 · 343 citations · Full text

Engineering, Riskbenefit Ratio, Quasi-experiment +17

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Inge M.W. Verberk, Elisabeth H. Thijssen, Jannet Koelewijn et al. · Alzheimer s Research & Therapy · 2020 · 251 citations · Full text

Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort

Arno de Wilde, Wiesje M. van der Flier, Wiesje Pelkmans et al. · JAMA Neurology · 2018 · 160 citations · Full text

The Alzheimer’s disease drug development landscape

Pieter van Bokhoven, Arno de Wilde, Lisa Vermunt et al. · Alzheimer s Research & Therapy · 2021 · 134 citations · Full text

Multitracer model for staging cortical amyloid deposition using PET imaging

Lyduine E. Collij, Fiona Heeman, Gemma Salvadó et al. · Neurology · 2020 · 93 citations · Full text